Episode 222: 222. Ablation for AFIB in patients with HFrEF
Consider ablation in patients who have an EF < 35% and atrial fibrillation the NNT for all cause mortality was 7 at 18 months https://www.nejm.org/doi/full/10.1056/NEJMoa2306037
19 Jan 20244min
Episode 221: 221. Nurse Led Sleep Restriction IMPROVES Insomnia
Sleep restriction therapy led by nurses with only 4 hours of education significantly improved patients insomnia at 6 months. More info HERE ___>https://thrive.kaiserpermanente.org/care-near-you/northe...
18 Jan 20246min
Episode 220: 220. Semaglutide at 1yr Gives Small Improvement in Questionnaire for those with HFpEF
Kansas City Cardiomyopathy Questionnaire clinical summary score was improved by 7.8 in those individuals with HFpEF that took semaglutide for one year compared to those that took placebo. This is a sm...
17 Jan 20245min
Episode 219: 219. Oral Iron better with vitamin C on an empty stomach
When taking Ferrous Fumarate a little bit of vitamin C or an 8 ounce glass of orange juice with an otherwise empty stomach will improve the absorption- this absorption is decreased with food and coffe...
16 Jan 20245min
Episode 218: 218. Semaglutide and CAD But No Diabetes - Decrease Event$$$$$$
https://www.nejm.org/doi/full/10.1056/NEJMoa2307563Semaglutide and CAD but no diabetes decreases events NNT of 66 at 40 months but a predicted price tag of 3.5 million dollars.
12 Jan 20247min
Episode 217: 217. Olanzapine 2.5mg for weight gain with advance cancer
Olanzapine 2.5mg for weight gain with advance cancer NNT of 50 for >5% weight gainhttps://pubmed.ncbi.nlm.nih.gov/36977285/
11 Jan 20245min
Episode 216: 216. AFIB- RATE or ABLATE-- New guidelines
ACC/AHA just came out with new guidelines on AFIB if you need some light reading material! (big take home rhythm not rate, and not equal, read below for more information) A HUGE piece of new is that n...
27 Des 20239min
Episode 215: 215. Enteric coated or uncoated aspirin, which is better or safer?
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial | Clinical Pharmacy and Pharmaco...
20 Des 20234min
